Gravity Diagnostics Expands Testing Services to Include Xylazine Detection: A Crucial Advancement in Ensuring Public Safety
20 sept. 2023 16h53 HE
|
Gravity Diagnostics
Covington, KY, Sept. 20, 2023 (GLOBE NEWSWIRE) -- **FOR IMMEDIATE RELEASE** [[Covington, KY] – [9/20/23] – Gravity Diagnostics, a leading clinical toxicology laboratory, is announcing a...
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences
07 sept. 2023 08h00 HE
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and...
Global Smoking Cessation & Nicotine De-Addiction Product Market 2023-2028: Featuring Players Pfizer, British American Tobacco, JUUL Labs & GSK PLC
30 août 2023 07h18 HE
|
Research and Markets
Dublin, Aug. 30, 2023 (GLOBE NEWSWIRE) -- The "Global Smoking Cessation & Nicotine De-Addiction Product Market (2023-2028) by Product, Distribution Channel, and Geography, Competitive Analysis,...
Oxford Treatment Center at Forefront of Equine-Assisted Therapy Research for Addiction
14 août 2023 14h57 HE
|
Oxford Treatment Center
OXFORD, Miss., Aug. 14, 2023 (GLOBE NEWSWIRE) -- Under the guidance of Dr. Katie Holtcamp, EAP, EAL, CCTP, Oxford Treatment Center, a leading provider of co-occurring substance use and mental health...
Las Vegas Alcohol Rehab
07 août 2023 10h00 HE
|
Gallus Medical Detox Centers
LAS VEGAS, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Gallus Medical Detox Center in Las Vegas, a leading provider of medically supervised detoxification services, is proud to share more on its alcohol detox...
Delivering Next Generation Addiction Recovery, Affect Therapeutics Raises $16 Million in Series A Funding Led by ARTIS Ventures
12 juil. 2023 07h00 HE
|
ARTIS Ventures
McLean, VA, July 12, 2023 (GLOBE NEWSWIRE) -- Affect Therapeutics (“Affect”), a company reimagining addiction treatment for the digital age, today announces a $16 million Series A led by...
Incannex Announces Intention to Redomicile to United States, List all Shares on Nasdaq
10 juil. 2023 07h30 HE
|
Incannex Healthcare
Highlights: Incannex to redomicile to the United States via a Scheme of Arrangement pursuant to Australian lawA newly formed Delaware corporation (Incannex Healthcare Inc.) will become the ultimate...
Substance Abuse Treatment Market to Grow at a CAGR of 8.5% during the 2023 to 2031 Forecast Period: TMR Study
10 juil. 2023 06h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, July 10, 2023 (GLOBE NEWSWIRE) -- The global substance abuse treatment market stood at US$ 10.2 billion in 2021 and the global market is projected to reach US$...
Incannex Receives Ethics Approval for Bioequivalence/Bioavailability Clinical Trial for IHL-42X, the Company’s Proprietary Drug for Treatment of Obstructive Sleep Apnoea (‘OSA’)
06 juil. 2023 08h42 HE
|
Incannex Healthcare
Highlights: Incannex has received approval from Bellberry Human Research Ethics Committee (‘HREC’) to commence the bioavailability/bioequivalence (‘BA/BE’) clinical trial to assess the...
Greenhouse Treatment Center Introduces Treatment Track Dedicated to Young Adults
05 juil. 2023 14h03 HE
|
Greenhouse Treatment Center
GRAND PRAIRIE, Texas, July 05, 2023 (GLOBE NEWSWIRE) -- Greenhouse Treatment Center, a leading provider of co-occurring mental health and substance use disorder treatment services, has announced the...